jRCT2071230002
Untitled Trial
Single and multiple dose escalation study to investigate safety, tolerability, pharmacokinetics, and pharmacodynamics of BAY 3283142 given as oral tablets in Japanese healthy male participants in a randomized, placebo controlled, single blind, group comparison design
Bayer Yakuhin, Ltd.·Japan Registry Clinical TrialCompleted
Study focus
- Disease/Condition
- Chronic kidney disease
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Bayer Yakuhin, Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Chronic kidney diseaseChronic kidney disease, unspecifiedChronic kidney disease, stage 1Chronic kidney disease, stage 4Chronic kidney disease, stage 2
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2071230002
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2071230002 through Pure Global AI's free database. This phase not specified trial is sponsored by Bayer Yakuhin, Ltd. and is currently Completed. The study focuses on Chronic kidney disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.